Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
13441
Table_1_Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and networ...
Published 2022“…</p>Result<p>We selected seven treatments and assessed the clinical trials in which they were tested against a placebo control. Of these treatments, intranasal insulin 20 IU (ITSN20), glucagon-like peptide-1 (GLP-1), and dipeptidyl peptidase 4 inhibitor (DPP-4) were associated with significantly improved MMSE scores (7 RCTs, 333 patients, 30≥MMSE score≥20: mild) compared with placebo [standardized mean difference (SMD) 1.11, 95% confidence interval (CI) (0.87, 1.35); SMD 0.75, 95% CI (0.04, 1.41); and SMD 4.08, 95% CI (3.39, 4.77), respectively]. …”
-
13442
-
13443
-
13444
-
13445
-
13446
-
13447
Effect of cilostazol on Aβ-induced cytotoxicity.
Published 2015“…<p>Decrease in cell viability in response to exogenous Aβ1–42 in N2a cells (A) and to endogenously overproduced Aβ in the N2aSwe cells (B), and the recovery by cilostazol in the absence and presence of 3-methyladenine (3-MA, 2.5 mM). …”
-
13448
-
13449
-
13450
-
13451
-
13452
-
13453
-
13454
-
13455
-
13456
-
13457
-
13458
-
13459
-
13460